The largest database of trusted experimental protocols

5 protocols using arca cap analog

1

In vitro Synthesis of Capped and Modified mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
TRAIL- and PTEN-bearing mRNAs were generated by in vitro transcription. The human 5′UTR with Kozak sequence and 3′UTR sequence were synthesized commercially by Integrated DNA Technologies (Coralville, Iowa) and sub-cloned into pcDNA3.3. Plasmid inserts were excised by restriction enzyme digestion and used to template tail PCRs. The templates of human TRAIL and PTEN were obtained from our previously constructed expression vectors [19 (link), 47 (link)]. MEGAscript T7 kit (Ambion) was used to synthesize mRNA. However, m7GpppG was replaced with ARCA cap analog (New England Biolabs) and cytidine and uridine were replaced with 5-methylcytidine triphosphate and pseudouridine triphosphate (TriLink Biotechnologies) respectively. Reactions were incubated 5 h at 37°C followed by DNase treatment. Then, the reactions were treated with Antarctic Phosphatase (New England Biolabs) for 2 h at 37°C to remove residual 5′-triphosphates. The synthesized RNA was purified with Ambion MEGAclear spin columns (Ambion) and quantitated by Nanodrop (Thermo Scientific).
+ Open protocol
+ Expand
2

In Vitro mRNA Synthesis and Transfection in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro mRNA synthesis and transfections were performed according to previous protocols.46 (link) In brief, T7 promoter and polyA tail were added by polymerase chain reaction (PCR) using KAPA taq kit (Kapabiosystems, London, UK). RNA was transcribed from the template using MEGAscript T7 kit (Ambion, Carlsbad, CA, USA), with ARCA cap analog (New England Biolabs, Ipswich, MA, USA); ATP; GTP; 5-Methyl-CTP (TriLink, San Diego, CA, USA); and pseudo-UTP (TriLink). Synthesized RNAs were purified with the MEGAclear kit (Ambion). RNA transfections were performed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. To increase the viability of transfected cells, B18R interferon inhibitor (eBioscience, San Diego, CA, USA) was supplemented to the culture medium. One day before transfection, 30,000 hESCs were seeded on a culture plate, and 1 µg/well of each synthetic modified mRNA was induced. The hESCs were subjected to four consecutive transfections with TF-encoding RNAs, or GFP or mCherry mRNAs as controls with Lipofectamine 2000 (Life Technologies) in StemFit AK-03 with B18R (eBioscience) for the first two days of differentiation. After two consecutive days of transfection, the culture medium was changed to DKSFM with 100 μg/mL CT and 10 ng/mL EGF.
+ Open protocol
+ Expand
3

Synthetic mRNA Transfection in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ORFs encoding TGIF2, PDX1, NeuroD1, and Mafa were cloned from mouse islet cDNA by polymerase chain reaction (PCR). In vitro transcribed template construction and RNA synthesis are schematized in Figure 1A. mRNAs were synthesized with the use of the MEGAscript T7 kit (Ambion) according to the manufacturer’s instructions. The reaction used ARCA cap analog (New England Biolabs), 5-methylcytidine triphosphate instead of cytidine and pseudouridine triphosphate instead of uridine (TriLink Biotechnologies). Reactions were incubated for 5 h at 37°C followed by Antarctic Phosphatase (New England Biolabs) treatment for 2 h at 37°C to remove residual triphosphates. The synthesized RNA was purified with Ambion MEGAclear spin columns (Ambion) and quantified using a Nanodrop spectrophotometer (Thermo Fisher Scientific). mRNA transfection was carried out with TransIT-mRNA (Mirus). In vitro transcribed mRNAs were diluted in Opti-MEM basal media (Gibco), followed by the addition of boost reagent and TransIT-mRNA sequentially. After 2 min incubation at room temperature (RT), the RNA–lipid complexes were delivered to the culture medium. Four hours later, the medium was replaced with normal culture medium.
+ Open protocol
+ Expand
4

In Vitro Synthesis of Therapeutic mRNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luc-mRNA, RFP-mRNA, and TRAIL-mRNAs were synthesized in vitro as previously described.32 (link) Briefly, the human 5′ UTR with Kozak sequence and 3′ UTR sequence were commercially synthesized by Integrated DNA Technologies (Coralville, IA) and sub-cloned into pcDNA3.3. The DNA templates of human TRAIL and luciferase were obtained from our previously constructed expression vectors through restriction enzyme digestion. MEGAscript T7 kit (Ambion) was used to synthesize mRNAs, whereas m7GpppG was replaced with ARCA cap analog (New England Biolabs) and cytidine and uridine were replaced with 5-methylcytidine triphosphate and pseudouridine triphosphate (TriLink Biotechnologies) respectively. Reactions were sustained for 5 h at 37°C followed by DNase treatment. Then, the reactions were treated with Antarctic Phosphatase (New England Biolabs) for 2 h at 37°C to remove residual 5′-triphosphates. The synthesized mRNAs were purified with Ambion MEGAclear spin columns (Ambion) and quantitated with Nanodrop (Thermo Fisher Scientific).
+ Open protocol
+ Expand
5

In Vitro Synthesis of mRNA Reporters

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro synthesis of Luc-mRNA and TRAIL-mRNA Luc-mRNA and TRAIL-mRNAs were synthesized in vitro as previously described [6] . Brie y, the human 5'UTR with Kozak sequence and 3'UTR sequence were commercially synthesized by Integrated DNA Technologies (Coralville, Iowa) and sub-cloned into pcDNA3.3. The DNA templates of human TRAIL and luciferase were obtained from our previously constructed expression vectors through restriction enzyme digestion. MEGAscript T7 kit (Ambion) was used to synthesize mRNAs, whereas m7GpppG was replaced with ARCA cap analog (New England Biolabs) and cytidine and uridine were replaced with 5methylcytidine triphosphate and pseudouridine triphosphate (TriLink Biotechnologies) respectively.
Reactions were sustained for 5 h at 37°C followed by DNase treatment. Then, the reactions were treated with Antarctic Phosphatase (New England Biolabs) for 2 h at 37°C to remove residual 5'-triphosphates. The synthesized mRNAs were puri ed with Ambion MEGAclear spin columns (Ambion) and quantitated with Nanodrop (Thermo Scienti c).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!